Back to search
Cerebral Palsy and Botulinum Toxin
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cerebral Palsy and Botulinum Toxin trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cerebral Palsy and Botulinum Toxin trials you may qualify forA cross-sectional design study will be carried out to explore the morphological muscle properties and alterations in muscle composition on a macroscopic level i…
Project Identification and Researchers Title: "Changes in functionality and quality of life when applying the botulinum toxin type A infiltration protocol in ch…
This study aimed to check and compare the effects of botulinum toxin injection combined with shock wave therapy versus botulinum toxin injection only for lower…
There is debate regarding the efficiency of different dilutions of Botulin toxin type A (BTX-A) injections. Some authors believe that highly diluted BTX-A injec…
This study in an observational, prospective and longitudinal study. The aim of the study is to evaluate the effect of botulinum toxin type A (BTX) injections in…
Cerebral palsy (CP) is a motor impairment due to a brain malformation or a brain lesion before the age of two. Spasticity, hypertonus in flexor muscles, dyscoor…
The aim of this study is to investigate the effects of Botulinum Neurotoxin-A (BoNT-A) injection applied to spastic muscles on pain sensation and Selective Moto…
Stroke is one of the leading causes of disability worldwide, particularly affecting the upper extremities and thus negatively impacting patients' activities of…
The aim of the study is to confirm the functional improvement obtained through treatment of spasticity on 2 agonist and antagonist muscles. The hypothesis is th…